Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ovarian serous tumor

Known as: Serous Neoplasm of Ovary, Serous Tumor of the Ovary, serous ovarian tumor 
A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of neoplastic epithelial cells that, in well… Expand
National Institutes of Health

Related topics

Related topics

7 relations
Epithelial CellsEpitheliumFemale Reproductive SystemNeoplastic Cell
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model
Background Recent evidence links aberrant activation of Hedgehog (Hh) signaling with the pathogenesis of several cancers… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2008
Highly Cited
2008
Multiple alternative splicing markers for ovarian cancer.
Intense efforts are currently being directed toward profiling gene expression in the hope of developing better cancer markers and… Expand
  • table 1
  • figure 1
  • figure 2
Highly Cited
2007
Highly Cited
2007
Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
PURPOSE To identify markers that can predict overall survival in patients with high-grade advanced stage serous adenocarcinomas… Expand
Review
2006
Review
2006
Patterns of Stromal Invasion in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): A Reevaluation of the Concept of Stromal Microinvasion
Stromal-epithelial patterns of invasion in serous tumors of the ovary have been subclassified as destructive and nondestructive… Expand
Highly Cited
2005
Highly Cited
2005
Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up
The natural history, classification, and nomenclature of ovarian serous tumors of low malignant potential (S-LMP) (serous tumors… Expand
Highly Cited
2005
Highly Cited
2005
Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations.
Activation of mitogen-activated protein kinase (MAPK) occurs in response to various growth stimulating signals and as a result of… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Highly Cited
2002
Highly Cited
2002
Response and Survival in Patients With Progressive or Recurrent Serous Ovarian Tumors of Low Malignant Potential
OBJECTIVE To evaluate the response to therapy and survival of patients with progressive or recurrent serous ovarian tumors of low… Expand
  • figure 1
  • figure 2
  • figure I
  • figure 3
  • table 2
Highly Cited
1998
Highly Cited
1998
DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer
Using RNA fingerprinting (RAP) strategy and Northern blot analysis, we identified a differentially expressed sequence DOC-2 which… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1986
Highly Cited
1986
Tumor Implantation After Diagnostic Laparoscopic Biopsy of Serous Ovarian Tumors of Low Malignant Potential
Two cases of tumor implants occurring in the abdominal trocar sites after diagnostic laparoscopic biopsies of ovarian papillary… Expand
Highly Cited
1984
Highly Cited
1984
Prognostic significance of nuclear DNA content in serous ovarian tumors.
Specimens from 73 serous ovarian cancers were examined with respect to DNA content of the tumor cells. The prognostic value of… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE